BioRestorative Therapies, Inc. Income Statement
BRTX|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
BioRestorative Therapies, Inc. reported $359,700 in revenue and $14M in net loss for FY2025. Revenue has grown at a 29.9% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $359.7K | $145.8K | $145.8K | $119.8K | $46.0K | $130.0K | $111.0K | $81.0K | $36.4K | $628.9K | $416.0K | $1.7K | $15.6K | $0 |
| Cost of Revenue | $23.8K | $28.1K | - | - | - | - | - | - | $102 | $261.5K | $213.8K | $208 | $1.3K | $0 |
| Gross Profit | $335.9K | $145.8K | $145.8K | - | - | - | - | - | $36.3K | $367.4K | $202.2K | $1.5K | $14.3K | $0 |
| SG&A Expense | $5.9M | $11.3M | $11.3M | $15.6M | $25.6M | $4.6M | $4.0M | $3.9M | $3.2M | $3.9M | $2.3M | $2.3M | $3.0M | $1.4M |
| R&D Expense | $10.1M | $4.0M | $4.0M | $3.5M | $729.1K | $1.7M | $1.5M | $2.2M | $2.9M | $2.1M | $1.4M | $1.6M | $756.8K | $12.0K |
| Operating Income | -$15.6M | -$15.2M | -$15.2M | -$19.0M | -$26.3M | -$8.4M | -$7.6M | -$8.4M | -$7.8M | -$7.2M | -$4.9M | -$4.8M | -$5.6M | -$3.6M |
| Interest Expense | - | $552.3K | - | - | - | - | - | - | $208.0K | $9.7K | $285.3K | $371.3K | $591.8K | $260.0K |
| Income Tax | - | - | - | - | - | - | - | - | - | - | $0 | $0 | - | - |
| Net Income | -$14.2M | -$10.4M | -$10.4M | -$18.5M | -$44.3M | -$14.6M | -$12.5M | -$9.4M | -$8.6M | -$7.9M | -$5.6M | -$5.8M | $0 | -$1.2M |
| EPS (Basic) | -$1.16 | -$2.47 | -$5.11 | -$37.30 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$1.16 | -$2.47 | -$5.11 | - | -$28.56 | -$0.66 | -$1.64 | -$1.74 | -$2.10 | -$3.20 | -$4.38 | -$0.35 | -$0.48 | -$0.01 |
| Shares Outstanding | 6.9M | 4.7M | 3.7M | 3.5M | 715.5K | 77.9M | 11.7M | 6.1M | 4.7M | 3.3M | 1.7M | 19.1M | 14.9M | 607.7M |
| Gross Margin | 93.4% | 100.0% | 100.0% | - | - | - | - | - | 99.7% | 58.4% | 48.6% | 87.6% | 91.6% | - |
| Operating Margin | -4350.1% | -10439.5% | -10439.5% | -15838.1% | -57191.0% | -6486.2% | -6889.8% | -10338.6% | -21414.0% | -1140.1% | -1183.3% | -282873.2% | -35746.1% | - |
| Profit Margin | -3959.4% | -7145.2% | -7145.2% | -15438.0% | -96311.5% | -11267.6% | -11277.3% | -11660.1% | -23755.4% | -1259.9% | -1343.2% | -342333.0% | 0.0% | - |